These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8740124)

  • 1. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development.
    Wilske B; Busch U; Fingerle V; Jauris-Heipke S; Preac Mursic V; Rössler D; Will G
    Infection; 1996; 24(2):208-12. PubMed ID: 8740124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
    Wilske B; Jauris-Heipke S; Lobentanzer R; Pradel I; Preac-Mursic V; Rössler D; Soutschek E; Johnson RC
    J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative finding in cross-protective activity of Japanese Borrelia isolates against infection with three species of Lyme disease Borrelia in outbred mice.
    Masuzawa T; Kurita T; Yanagihara Y
    Microbiol Immunol; 1997; 41(9):733-6. PubMed ID: 9343825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.
    Wilske B; Busch U; Eiffert H; Fingerle V; Pfister HW; Rössler D; Preac-Mursic V
    Med Microbiol Immunol; 1996 Feb; 184(4):195-201. PubMed ID: 8811652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.
    Wilske B; Preac-Mursic V; Göbel UB; Graf B; Jauris S; Soutschek E; Schwab E; Zumstein G
    J Clin Microbiol; 1993 Feb; 31(2):340-50. PubMed ID: 8432821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of OspA serotypes for Borrelia burgdorferi sensu lato from Japan, Europe and North America.
    Masuzawa T; Wilske B; Komikado T; Suzuki H; Kawabata H; Sato N; Muramatsu K; Sato N; Isogai E; Isogai H; Johnson RC; Yanagihara Y
    Microbiol Immunol; 1996; 40(8):539-45. PubMed ID: 8887347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC.
    Jauris-Heipke S; Liegl G; Preac-Mursic V; Rössler D; Schwab E; Soutschek E; Will G; Wilske B
    J Clin Microbiol; 1995 Jul; 33(7):1860-6. PubMed ID: 7665660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden.
    Ornstein K; Berglund J; Nilsson I; Norrby R; Bergström S
    J Clin Microbiol; 2001 Apr; 39(4):1294-8. PubMed ID: 11283044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes.
    Lebech AM; Hansen K; Wilske B; Theisen M
    Med Microbiol Immunol; 1994 Dec; 183(6):325-41. PubMed ID: 7541107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis.
    Vasiliu V; Herzer P; Rössler D; Lehnert G; Wilske B
    Med Microbiol Immunol; 1998 Oct; 187(2):97-102. PubMed ID: 9832323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species.
    Will G; Jauris-Heipke S; Schwab E; Busch U; Rössler D; Soutschek E; Wilske B; Preac-Mursic V
    Med Microbiol Immunol; 1995 Aug; 184(2):73-80. PubMed ID: 7500914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
    Comstedt P; Schüler W; Meinke A; Lundberg U
    PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.
    Nayak A; Schüler W; Seidel S; Gomez I; Meinke A; Comstedt P; Lundberg U
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
    Probert WS; Crawford M; Cadiz RB; LeFebvre RB
    J Infect Dis; 1997 Feb; 175(2):400-5. PubMed ID: 9203661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping of Borrelia from formalin-fixed paraffin-embedded skin biopsies of cutaneous borreliosis and tick bite reactions by assays targeting the intergenic spacer region, ospA and ospC genes.
    Brandt FC; Ertas B; Falk TM; Metze D; Böer-Auer A
    Br J Dermatol; 2014 Sep; 171(3):528-43. PubMed ID: 24471698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans.
    Fingerle V; Liegl G; Munderloh U; Wilske B
    Med Microbiol Immunol; 1998 Oct; 187(2):121-6. PubMed ID: 9832327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.